Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC
Patients with HCC undergoing Atezo/Bev treatment, diagnosed with PD-multiple (not solely based on IH or EHS) or PD-MVI, experienced poor prognosis, specifically in terms of OS.
Authors
- Hideko Ohama (ORCID: https://orcid.org/0000-0002-1882-824X)
- Norio Itokawa (ORCID: https://orcid.org/0009-0002-2390-6692)
- Joji Tani (ORCID: https://orcid.org/0000-0001-8801-2505)
- Kazunari Tanaka (ORCID: https://orcid.org/0000-0001-9811-2665)
- Tomomitsu Matono
- Kazuhito Kawata (ORCID: https://orcid.org/0000-0002-4986-8578)
- Kazuya Kariyama (ORCID: https://orcid.org/0000-0003-3996-7502)
- Hidenori Toyoda (ORCID: https://orcid.org/0000-0002-1652-6168)
- Hirayuki Enomoto (ORCID: https://orcid.org/0000-0003-1334-1149)
- Kazuhiro Nouso (ORCID: https://orcid.org/0000-0002-2018-0008)
- Takeshi Hatanaka (ORCID: https://orcid.org/0000-0003-3656-285X)
- Masatoshi Kudo (ORCID: https://orcid.org/0000-0002-4102-3474)
- Yoichi Hiasa (ORCID: https://orcid.org/0000-0003-4117-339X)
- Atsushi Hiraoka (ORCID: https://orcid.org/0000-0003-1989-0480)
- Takashi Kumada (ORCID: https://orcid.org/0000-0003-2211-495X)
- Yoshiko Nakamura
- Shinya Fukunishi (ORCID: https://orcid.org/0000-0001-6930-2814)
- Tomomi Okubo (ORCID: https://orcid.org/0000-0003-1244-4736)
- Takuya Nagano (ORCID: https://orcid.org/0000-0003-1043-8033)
- Ei Itobayashi (ORCID: https://orcid.org/0000-0003-0475-2819)
- Masaki Kaibori (ORCID: https://orcid.org/0000-0002-0577-3921)
- Masashi Hirooka (ORCID: https://orcid.org/0000-0001-5634-5313)
- Chikara Ogawa (ORCID: https://orcid.org/0000-0002-4534-6692)
- Hiroki Nishikawa (ORCID: https://orcid.org/0000-0003-3489-2740)
- Hisashi Kosaka (ORCID: https://orcid.org/0000-0002-2926-9973)
- Kazuto Tajiri (ORCID: https://orcid.org/0000-0002-2373-8601)
- Takashi Nishimura (ORCID: https://orcid.org/0000-0002-5517-8303)
- Toshifumi Tada (ORCID: https://orcid.org/0000-0002-0976-6761)
- Atsushi Naganuma (ORCID: https://orcid.org/0000-0003-0663-0102)
- Akemi Tsutsui (ORCID: https://orcid.org/0000-0003-2978-2723)
- Hidekatsu Kuroda (ORCID: https://orcid.org/0000-0002-1471-1087)
- Toru Ishikawa (ORCID: https://orcid.org/0000-0002-5470-9694)
- Yutaka Yata (ORCID: https://orcid.org/0000-0002-4592-3509)
- Masanori Atsukawa (ORCID: https://orcid.org/0000-0003-3374-7111)
- Yuichi Koshiyama (ORCID: https://orcid.org/0009-0006-1247-1215)
- Tomoko Aoki (ORCID: https://orcid.org/0000-0002-9950-4553)
- Fujimasa Tada (ORCID: https://orcid.org/0009-0007-3964-5876)
- Asahiro Morishita (ORCID: https://orcid.org/0000-0002-0760-3045)
- Koichi Takaguchi (ORCID: https://orcid.org/0000-0003-0175-8721)
- Michitaka Imai (ORCID: https://orcid.org/0000-0001-6448-6036)
- Satoru Kakizaki (ORCID: https://orcid.org/0000-0003-0224-7093)
- Osamu Yoshida
- Taeang Arai
- Shinichiro Nakamura
- Kunihiko Tsuji
Institutions
- Kansai Medical University (JP)
- Iwate Medical University (JP)
- Kagawa University (JP)
- Hamamatsu University School of Medicine (JP)
- Takamatsu Red Cross Hospital (JP)
- Saiseikai Niigata Daini Hospital (JP)
- National Hospital Organization Takasaki Medical Center (JP)
- Okayama Prefecture (JP)
- Ogaki Municipal Hospital (JP)
- Himeji Medical Center (JP)
- Hanwa Memorial Hospital (JP)
- Gunma Saiseikai Maebashi Hospital (JP)
- Himeji Red Cross Hospital (JP)
- Teine Keijinkai Hospital (JP)
- Asahi General Hospital (JP)
- Toyama University Hospital (JP)
- Ehime Prefectural Central Hospital (JP)
- Kagawa Prefectural Central Hospital (JP)
- Takarazuka City Hospital (JP)
- Ehime University (JP)
- Gifu Kyoritsu University (JP)
- Kobe University (JP)
- Nippon Medical School (JP)
- Hyogo University (JP)
- Osaka University of Pharmaceutical Sciences (JP)
- Kindai University (JP)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1111/jgh.16884
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00